V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 2,150 shares at $89.76 ($193K) on 2019-03-27, disclosed to the SEC on 2019-03-29.
Open-market sale of $193k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2023-04-04 | $825K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |